We are thrilled to announce that 3 new projects have been selected by the Paris Saclay Cancer Cluster (PSCC) to benefit from its support: @Celeos, @Robeaute, and Panca.
Today's shortlist highlights cutting-edge advances in medical devices and AI, with a focus on improving surgery and precision oncology. Celeos and Robeaute stand out for their innovative approaches to refining surgical procedures and advancing cancer treatment and monitoring.
@Celeos develops an AI-based surgery guidance system to ensure the complete removal of cancer cells during the first operation.
@Robeaute, introduces a unique modular microrobot for neurosurgical interventions that can be guided in 3D within the brain to perform various tasks.
In addition, we are excited to introduce Panca, a novel therapeutic project from Marseille focused on pancreatic cancer, a disease with significant unmet medical need. These developments represent a promising leap forward in oncology and are set to improve patient care and outcomes.
With 39 cutting-edge oncology projects selected and supported, the #PSCC offers the most promising developers access to a comprehensive array of resources to accelerate innovation in oncology: expertise, networking, financing, data, samples, technologies, infrastructures, training, laboratories.
Do you develop an innovative solution for patients in oncology? Come and join us: https://lnkd.in/eTYvAZV7
Comments